Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
about
Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective studyNovel therapeutics for Alzheimer's disease: an updateCoenzyme Q and Its Role in the Dietary Therapy against AgingiTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: understanding the interface between physiology and diseaseAntioxidant treatment with coenzyme Q-ter in prevention of gentamycin ototoxicity in an animal model.Acetate supplementation modulates brain adenosine metabolizing enzymes and adenosine A₂A receptor levels in rats subjected to neuroinflammation.Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicityAcetyl L-carnitine protects motor neurons and Rohon-Beard sensory neurons against ketamine-induced neurotoxicity in zebrafish embryos.Neuroproteomics as a promising tool in Parkinson's disease research.The role of mitochondria in reactive oxygen species metabolism and signaling.Mitochondrial Drugs for Alzheimer Disease.Biochemical rationale and experimental data on the antiaging properties of CoQ(10) at skin level.Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism.The heme precursor delta-aminolevulinate blocks peripheral myelin formation.Impaired spare respiratory capacity in cortical synaptosomes from Sod2 null mice.Crystallization and preliminary crystallographic studies of UbiG, an O-methyltransferase from Escherichia coliFrontiers in Alzheimer's disease therapeutics.Oxidative stress in neurodegenerationSuppression of the proinflammatory response of metastatic melanoma cells increases TRAIL-induced apoptosisStatins, plasma cholesterol, and risk of Parkinson's disease: a prospective studyMitochondrial respiration deficits driven by reactive oxygen species in experimental temporal lobe epilepsy.Enrichment of coenzyme Q10 in plasma and blood cells: defense against oxidative damageMitochondrial avid radioprobes. Preparation and evaluation of 7'(Z)-[125I]iodorotenone and 7'(Z)-[125I]iodorotenol.Behavioral improvement after chronic administration of coenzyme Q10 in P301S transgenic mice.Mitochondria as a therapeutic target for aging and neurodegenerative diseases.Evidence of early involvement of apoptosis inducing factor-induced neuronal death in Alzheimer brainEndogenous synthesis of coenzyme Q in eukaryotes.CoQ10 deficiency diseases in adults.Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's diseaseOxidative stress and NAD+ in ischemic brain injury: current advances and future perspectives.Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease.Improvement of coenzyme Q10 production: mutagenesis induced by high hydrostatic pressure treatment and optimization of fermentation conditions.Human coenzyme Q10 deficiencyStructural insights into the methyl donor recognition model of a novel membrane-binding protein UbiGCoenzyme Q10 levels are low and associated with increased mortality in post-cardiac arrest patientsAntioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures.Redox imbalance in Parkinson's disease.Antioxidants in central nervous system diseases: preclinical promise and translational challenges.Nutraceuticals against Neurodegeneration: A Mechanistic Insight.Cytochrome b5 reductase, a plasma membrane redox enzyme, protects neuronal cells against metabolic and oxidative stress through maintaining redox state and bioenergetics.
P2860
Q21261409-AC931261-2301-419D-9C65-B47E084BB271Q24620383-62F4D376-01C6-4D13-9BB9-16F8B40E9565Q26753050-5D6BD0E6-0189-422C-BA52-F6F7AD0DBF4CQ27300851-C293EEC9-AE26-4EED-A947-B3AF21C684C7Q30465930-723BFD8C-FB16-4A65-A759-B472BD4A3F8CQ33730081-3C798BBB-FD1F-4039-AB5D-C99CFAECBDCEQ33784466-AC6EBB65-7D99-42D1-816E-F7CC3DED2BFFQ33787815-211DDBE9-D1E2-420E-8864-2FAE9DB191FEQ33821316-C2E94B23-20FD-4005-A4FB-577993EBC4B2Q33849198-9D92F908-E6A0-4D69-9B61-58EA74C1FDA2Q34016406-774B15F4-183E-4697-8802-5BEA21BD5969Q34046916-78A836E2-7F43-4F03-B47E-0A100549622BQ34584417-1DD7E7B9-EFC0-49B2-9064-8BE15F2E4681Q34594889-182B7B18-CE46-419F-AA99-52988961C28EQ34701481-2A93D181-7D65-4FB6-9B51-824D60C67BA7Q35021507-02C9318A-85AD-4FEC-A7E7-D91D9A6D132AQ35086876-50BD32F3-33D9-4FEF-8154-71DEB1C99D89Q35224677-D7EA420A-3C29-4118-944D-85BBA9D97075Q35230726-433E33AA-89FA-4BA0-AD46-C03742B9700CQ35328089-82E59903-B694-4CB3-A362-C041F159BB37Q35736503-8255A91B-54AF-491C-A093-53399A9746DCQ35751601-CD911B4E-F310-4444-975E-4EF54C61F555Q35752002-6800AA4E-B352-45E2-A3BA-BBD559B3F2A5Q35756089-8A964D88-227F-41F7-8585-EAA45BEF1F99Q35807409-2C75DC86-7772-4E00-B625-5AF56CD2B439Q35895207-5C9F54CF-6936-4674-B275-E301A56B4AF9Q35987676-A3DCC63B-0A2F-4073-BBCC-480CC7FB300DQ36026895-6AEE0DDE-0012-4EEF-8F05-1A58A16AF0A6Q36054722-77267115-8896-47DB-8BF7-7B13B7891989Q36090617-C8216ACC-8AB1-4E2A-9997-B5071721AFBAQ36202527-E33C7267-50BE-4AE2-9AAC-06D7B351EA4CQ36308806-3DEBB532-2D32-4606-9CA9-7F2C314395E8Q36648798-E9528D38-C64A-44CE-9281-F68C2881B700Q36699708-71D904A0-8C00-4A64-8280-907FBB2FBE1BQ36856037-EE2487E3-66F8-4DC6-AADE-104DBB2CC293Q36866566-6E602BA9-317F-4439-9478-4DBC84C9ED74Q36899782-7DD907BE-23D0-4135-B1DF-A67DDF132262Q37159979-952E9FFC-BE9C-45E4-891D-64F29D2EBE36Q37168739-7876504F-AF2C-40B6-9B9F-0B9BAD966880Q37219429-2334648C-9D58-4E3B-BB4F-61EC2B68ED28
P2860
Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Mitochondrial dysfunction and ...... Q10 as a potential treatment.
@ast
Mitochondrial dysfunction and ...... Q10 as a potential treatment.
@en
type
label
Mitochondrial dysfunction and ...... Q10 as a potential treatment.
@ast
Mitochondrial dysfunction and ...... Q10 as a potential treatment.
@en
prefLabel
Mitochondrial dysfunction and ...... Q10 as a potential treatment.
@ast
Mitochondrial dysfunction and ...... Q10 as a potential treatment.
@en
P921
P1476
Mitochondrial dysfunction and ...... Q10 as a potential treatment.
@en
P2093
M Flint Beal
P304
P356
10.1023/B:JOBB.0000041772.74810.92
P577
2004-08-01T00:00:00Z
P5875
P6179
1007772280